“…The clinical forms of leishmaniasis include cutaneous leishmaniasis (CL; localized or diffuse), which is characterized by ulcerative lesions on the skin; mucocutaneous leishmaniasis (MCL), which results in destruction of mucosal tissue; and visceral leishmaniasis (VL, or Kala-Azar), which affects various organs and is potentially lethal (Salotra et al 2005, Reithinger et al 2007, World Health Organization 2010, Stockdale et al 2013. In Mexico, Leishmania infantum, L. braziliensis, and L. mexicana have been reported as the causative agents of human leishmaniasis (Sanchez-Tejeda et al 2001, Pérez-Vega et al 2009, Ochoa-Diaz et al 2012, and the last two species are primarily responsible for MCL and CL lesions, respectively. CL is the major endemic form of the disease and has spread across 17 states in Mexico, whereas VL has been found in only two states, Guerrero and Morelos, and MCL has also been reported in two states, Tabasco and Chiapas (World Health Organization 2010, Pérez-Vega et al 2009, Ochoa-Diaz et al 2012.…”